Variant report
Variant | esv3443663 |
---|---|
Chromosome Location | chr4:56499192-56499527 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:61)
- Chromatin interactive region (count:1)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | EP300 | chr4:56499515-56499758 | GM12878 | blood: | n/a | n/a |
2 | PML | chr4:56498736-56499200 | K562 | blood: | n/a | n/a |
3 | POLR2A | chr4:56499478-56502006 | K562 | blood: | n/a | n/a |
4 | POLR2A | chr4:56499394-56503785 | K562 | blood: | n/a | n/a |
5 | TBL1XR1 | chr4:56499512-56501926 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:56499522-56499572 | HPAEpiC | pulmonary alveolar: | n/a |
2 | chr4:56499522-56499572 | HEEpiC | esophagus: | n/a |
3 | chr4:56499522-56499572 | HCM | heart: | n/a |
4 | chr4:56499522-56499572 | ProgFib | skin: | n/a |
5 | chr4:56499522-56499572 | Hela-S3 | cervix: | n/a |
6 | chr4:56499522-56499572 | HIPEpiC | eye: | n/a |
7 | chr4:56499522-56499572 | HNPCEpiC | eye: | n/a |
8 | chr4:56499522-56499572 | AG09319 | gingival: | n/a |
9 | chr4:56499522-56499572 | GM12878 | blood: | n/a |
10 | chr4:56499522-56499572 | IMR90 | lung: | fetal |
11 | chr4:56499522-56499572 | BE2_C | brain: | n/a |
12 | chr4:56499522-56499572 | PANC-1 | pancreas: | n/a |
13 | chr4:56499522-56499572 | HEK293 | kidney: | embryo |
14 | chr4:56499522-56499572 | Caco-2 | colon: | n/a |
15 | chr4:56499522-56499572 | AG10803 | skin: | n/a |
16 | chr4:56499522-56499572 | HCPEpiC | choroid plexus: | n/a |
17 | chr4:56499522-56499572 | AoSMC | blood vessel: | n/a |
18 | chr4:56499522-56499572 | HepG2 | liver: | n/a |
19 | chr4:56499522-56499572 | Hepatocyte | liver: | n/a |
20 | chr4:56499522-56499572 | NT2-D1 | testis: | n/a |
21 | chr4:56499522-56499572 | HAEpiC | amniotic membrane: | n/a |
22 | chr4:56499522-56499572 | PrEC | prostate: | n/a |
23 | chr4:56499522-56499572 | AG04450 | lung: | fetal |
24 | chr4:56499522-56499572 | NHDF-neo | bronchial: | n/a |
25 | chr4:56499522-56499572 | GM19239 | blood: | n/a |
26 | chr4:56499522-56499572 | CMK | blood: | n/a |
27 | chr4:56499522-56499572 | Jurkat | blood: | n/a |
28 | chr4:56499522-56499572 | AG09309 | skin: | n/a |
29 | chr4:56499522-56499572 | K562 | blood: | n/a |
30 | chr4:56499522-56499572 | NH-A | brain: | n/a |
31 | chr4:56499522-56499572 | NB4 | blood: | n/a |
32 | chr4:56499522-56499572 | GM12892 | blood: | n/a |
33 | chr4:56499522-56499572 | U87 | brain: | n/a |
34 | chr4:56499522-56499572 | SK-N-SH_RA | brain: | n/a |
35 | chr4:56499522-56499572 | AG04449 | skin: | fetal |
36 | chr4:56499522-56499572 | MCF10A-Er-Src | breast: | n/a |
37 | chr4:56499522-56499572 | HUVEC | blood vessel: | n/a |
38 | chr4:56499522-56499572 | NHBE | bronchial: | n/a |
39 | chr4:56499522-56499572 | HL-60 | blood: | n/a |
40 | chr4:56499522-56499572 | T-47D | breast: | n/a |
41 | chr4:56499522-56499572 | SAEC | small airway: | n/a |
42 | chr4:56499522-56499572 | HRCEpiC | kidney: | n/a |
43 | chr4:56499522-56499572 | BJ | skin: | n/a |
44 | chr4:56499522-56499572 | SKMC | muscle: | n/a |
45 | chr4:56499522-56499572 | A549 | lung: | n/a |
46 | chr4:56499522-56499572 | HCT-116 | colon: | n/a |
47 | chr4:56499522-56499572 | HCF | heart: | n/a |
48 | chr4:56499522-56499572 | HRE | kidney: | n/a |
49 | chr4:56499522-56499572 | GM12891 | blood: | n/a |
50 | chr4:56499522-56499572 | SK-N-MC | brain: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:56407970..56411777-chr4:56498734..56501001,3 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-NMU-2 | chr4:56499346-56499878 | l_2648_chr4:56499345-56508927_adipose |
No data |
No data |
Variant related genes | Relation type |
---|---|
NMU | TF binding region |
NMU | CpG island |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs149984758 | chr4:56499197-56499198 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs68194044 | chr4:56499198-56499199 | Enhancers Weak transcription Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs56665930 | chr4:56499205-56499206 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs569487665 | chr4:56499215-56499216 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs139910474 | chr4:56499217-56499218 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs55893990 | chr4:56499220-56499221 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs547752482 | chr4:56499229-56499230 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs567838162 | chr4:56499230-56499231 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs56156718 | chr4:56499251-56499252 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs553583098 | chr4:56499253-56499254 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576616534 | chr4:56499258-56499259 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1906674 | chr4:56499267-56499268 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs556184747 | chr4:56499268-56499269 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs56189453 | chr4:56499274-56499275 | Weak transcription Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs530536082 | chr4:56499287-56499288 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs146552459 | chr4:56499293-56499294 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs561236550 | chr4:56499301-56499302 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs369471253 | chr4:56499313-56499314 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575013940 | chr4:56499318-56499319 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs7678236 | chr4:56499319-56499320 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs372458502 | chr4:56499335-56499336 | Weak transcription Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560715371 | chr4:56499349-56499350 | Weak transcription Enhancers Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs577427887 | chr4:56499353-56499354 | Weak transcription Enhancers Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs56710169 | chr4:56499384-56499385 | Weak transcription Enhancers Active TSS | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs552699415 | chr4:56499386-56499387 | Weak transcription Enhancers Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs56268402 | chr4:56499397-56499398 | Weak transcription Enhancers Active TSS | TF binding regionlncRNA | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs372485287 | chr4:56499410-56499411 | Weak transcription Enhancers Active TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs151270447 | chr4:56499476-56499477 | Weak transcription Enhancers Active TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs7657328 | chr4:56499501-56499502 | Weak transcription Enhancers Active TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs545585061 | chr4:56499502-56499503 | Weak transcription Enhancers Active TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs71192030 | chr4:56499503-56499504 | Weak transcription Enhancers Active TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs397993443 | chr4:56499516-56499517 | Weak transcription Enhancers Active TSS | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Lung cancer | 18438408 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Glioblastoma | 17504929 | CNVD |
Glioblastoma | 16823502 | CNVD |
Melanoma | 16908931 | CNVD |
Glioblastoma | 20031968 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Gastrointestinal stromal cancer | 17438095 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 19208797 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 19115005 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 22183965 | CNVD |
Autism | 22543975 | CNVD |
Breast cancer | 21785460 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:56493400-56500200 | Weak transcription | H1 Cell Line | embryonic stem cell |
2 | chr4:56494000-56500600 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
3 | chr4:56498000-56500200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr4:56498200-56499200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr4:56498200-56499800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
6 | chr4:56498400-56499200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr4:56498400-56499600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
8 | chr4:56498600-56499600 | Active TSS | K562 | blood |
9 | chr4:56498800-56499800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr4:56498800-56500000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr4:56499000-56499600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr4:56499000-56499800 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
13 | chr4:56499000-56500000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
14 | chr4:56499200-56499600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
15 | chr4:56499200-56499600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
16 | chr4:56499400-56501000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |